Portland Global Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-989
Closed -$226K 147
2025
Q4
$226K Hold
989
0.02% 139
2025
Q3
$229K Buy
+989
New +$201K 0.03% 137
2023
Q4
Sell
-1,391
Closed -$207K 129
2023
Q3
$207K Buy
+1,391
New +$204K 0.03% 119
2023
Q2
Sell
-1,601
Closed -$255K 125
2023
Q1
$255K Sell
1,601
-234
-13% -$35.8K 0.04% 120
2022
Q4
$297K Sell
1,835
-142
-7% -$21.8K 0.05% 118
2022
Q3
$265K Sell
1,977
-108
-5% -$15.5K 0.05% 118
2022
Q2
$319K Sell
2,085
-62
-3% -$9.47K 0.06% 113
2022
Q1
$348K Sell
2,147
-163
-7% -$23.7K 0.06% 117
2021
Q4
$313K Sell
2,310
-71
-3% -$8.39K 0.05% 127
2021
Q3
$257K Hold
2,381
0.05% 141
2021
Q2
$268K Sell
2,381
-300
-11% -$33.8K 0.05% 136
2021
Q1
$290K Hold
2,681
0.06% 119
2020
Q4
$287K Sell
2,681
-1,327
-33% -$128K 0.07% 115
2020
Q3
$351K Sell
4,008
-15
-0.4% -$1.41K 0.1% 85
2020
Q2
$395K Buy
+4,023
New +$354K 0.13% 73
2019
Q3
Sell
-2,809
Closed -$204K 111
2019
Q2
$204K Buy
2,809
+216
+8% +$17K 0.07% 111
2019
Q1
$209K Hold
2,593
0.07% 104
2018
Q4
$239K Sell
2,593
-50
-2% -$4.4K 0.1% 89
2018
Q3
$250K Hold
2,643
0.09% 91
2018
Q2
$245K Buy
2,643
+161
+6% +$15.7K 0.09% 90
2018
Q1
$235K Hold
2,482
0.09% 89
2017
Q4
$240K Sell
2,482
-105
-4% -$9.9K 0.09% 91
2017
Q3
$230K Buy
+2,587
New +$197K 0.09% 94

Other funds holding ABBV

Portland Global Advisors's ABBV Position: Q1 2026 in Review

Portland Global Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 989 shares — an estimated $226K sold.

Portland Global Advisors first reported a position in ABBV in Q3 2017 and held it in 23 quarters. The position peaked at $395K in Q2 2020. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Portland Global Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Portland Global Advisors sold 989 AbbVie shares in Q1 2026, an estimated $226K.
  • Portland Global Advisors first reported a position in AbbVie in Q3 2017 and held it in 23 quarters.
  • Portland Global Advisors's AbbVie position peaked at $395K in Q2 2020.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.